throbber
Case 1:19-cv-01681-CFC-SRF Document 1-8 Filed 09/10/19 Page 1 of 9 PageID #: 197
`
`
`
`
`EXHIBIT 8
`
`Columbia Ex. 2031
`Illumina, Inc. v. The Trustees
`of Columbia University
`in the City of New York
`IPR2020-01177
`
`

`

`Case 1:19-cv-01681-CFC-SRF Document 1-8 Filed 09/10/19 Page 2 of 9 PageID #: 198
`
`U.S. Pat. No. 10,407,459
`
`1. An adenine deoxyribonucleotide analogue having the
`structure:
`
`EXHIBIT 8
`
`Infringement by Illumina’s nucleotide
`analogues in the Accused Kits
`Bentley et al., Nature, Vol. 456:53-59 (2008) (“Bentley”) (Exhibit 4)
`Supplementary Information to Bentley (Exhibit 5)
`Milton et al., WO 2004018497 A2 (2004) (Exhibit 12)
`Illumina’s sequencing chemistry uses adenine deoxyribonucleotide
`analogues.
`“To ensure base-by-base nucleotide incorporation in a stepwise manner,
`we used a set of four reversible terminators, 3′-O-azidomethyl 2′-
`deoxynucleoside triphosphates (A, C, G and T), each labelled with a
`different removable fluorophore (Supplementary Fig. 1a).” Ex. 4 at 53.
`
`0
`0
`0
`II
`II
`11
`o-- i- o- r- o- ,- 0
`o·
`o·
`
`o-
`
`Ex. 5 at 14, Fig. 1a. Although only the structure for a thymine
`deoxyribonucleotide analogue is provided, Bentley indicates that the A, C,
`and G nucleotides have the same general structure. Ex. 4 at 53.
`On information and belief, Illumina uses an adenine deoxyribonucleotide
`
`1
`
`

`

`Case 1:19-cv-01681-CFC-SRF Document 1-8 Filed 09/10/19 Page 3 of 9 PageID #: 199
`
`analogue with a linker attached to the 7-deaza position of the adenine as
`shown in the claimed structure. Ex. 12 at 83, compound 32 (showing a
`linker attached to the 7-deaza position of an adenine).
`As shown in Fig. 1a of Supplementary Information to Bentley, Illumina
`uses an azidomethyl group (CH2N3) at position R (highlighted below).
`The azidomethyl group is a small chemically cleavable, chemical group,
`does not contain a ketone group, and is not a –CH2CH=CH2 group.
`
`wherein R (a) represents a small, chemically cleavable,
`chemical group capping the oxygen at the 3′ position of
`the deoxyribose of the deoxyribonucleotide analogue,
`(b) does not interfere with recognition of the analogue as
`a substrate by a DNA polymerase, (c) is stable during a
`DNA polymerase reaction, (d) does not contain a ketone
`group, and (e) is not a –CH2CH=CH2 group;
`
`wherein OR is not a methoxy group or an ester group;
`
`a
`
`Yo
`
`;__
`
`~o '
`
`N~o.._ _,,,....._ _ I'
`
`'
`
`-
`
`N~~ Q
`~ A-__,,O~ o
`~ , y---'
`
`o
`
`0~
`
`O'-../ N,
`
`0
`
`Ex. 5 at 14, Fig. 1a. Illumina uses these modified nucleotides for
`sequencing. Ex. 4 at 53 (“We sequenced DNA templates by repeated
`cycles of polymerase-directed single base extension.”). Since Illumina
`uses these nucleotides successfully in a polymerase reaction to
`accomplish DNA sequencing, it follows that the azidomethyl group does
`not interfere with recognition of the analogue as a substrate by a DNA
`polymerase and is stable during a DNA polymerase reaction.
`
`Illumina uses an azidomethyl group to cap the 3′-OH of its nucleotide to
`form an OR moiety. This OR moiety is not a methoxy group or an ester
`group.
`
`wherein the covalent bond between the 3′-oxygen and R As Illumina uses nucleotides with an azidomethyl group “[t]o ensure
`base-by-base nucleotide incorporation in a stepwise manner,” it follows
`
`2
`
`

`

`Case 1:19-cv-01681-CFC-SRF Document 1-8 Filed 09/10/19 Page 4 of 9 PageID #: 200
`
`is stable during a DNA polymerase reaction;
`
`that the bond between the 3′-oxygen and R is stable during a DNA
`polymerase reaction. Ex. 4 at 53.
`
`wherein tag represents a detectable fluorescent moiety; As shown in Fig. 1a below, Illumina’s modified nucleotides contain a
`fluorescent moiety tag (highlighted below).
`
`{I
`
`HN
`
`0
`
`'
`
`Y N~O
`A
`~ 0
`'t)
`
`II
`0
`
`H
`
`~
`
`N,
`1·
`o~o
`
`0
`
`~o "~~ Q
`lSJJ "
`'('--"
`
`0
`
`wherein Y represents a chemically cleavable, chemical
`linker which (a) does not interfere with recognition of
`the analogue as a substrate by a DNA polymerase and
`(b) is stable during a DNA polymerase reaction; and
`
`O'-../N,
`
`Ex. 5 at 14, Fig. 1a.
`
`As shown in Fig. 1a below, Illumina’s modified nucleotides use a
`chemically cleavable linker (highlighted below).
`
`{I
`
`Ex. 5 at 14, Fig. 1a. Illumina has indicated that this linker is chemically
`cleavable using tris(2-carboxyethyl)phosphine (TCEP). Ex. 4 at 53.
`
`As Illumina “sequenced DNA templates by repeated cycles of
`polymerase-directed single base extension” using nucleotides with this
`
`3
`
`

`

`Case 1:19-cv-01681-CFC-SRF Document 1-8 Filed 09/10/19 Page 5 of 9 PageID #: 201
`
`wherein the adenine deoxyribonucleotide analogue:
`
`i)
`
`ii)
`
`iii)
`
`iv)
`
`v)
`
`is recognized as a substrate by a DNA
`polymerase,
`
`is incorporated at the end of a growing strand of
`DNA during a DNA polymerase reaction,
`
`produces a 3′-OH group on the deoxyribose upon
`cleavage of R,
`
`no longer includes a tag on the base upon
`cleavage of Y, and
`
`is capable of forming hydrogen bonds with
`thymine or a thymine nucleotide analogue.
`
`2. An adenine deoxyribonucleotide analogue having the
`structure:
`
`linker, it follows that this linker (a) does not interfere with recognition of
`the analogue as a substrate by a DNA polymerase and (b) is stable during
`a DNA polymerase reaction. Ex. 4 at 53 (emphasis added); Ex. 5 at 33,
`Figure S13 (showing “Illumina sequence reads” identifying the A base
`resulting from incorporation by a DNA polymerase of an adenine
`deoxyribonucleotide analogue having a label attached via a chemically
`cleavable, chemical linker); Ex. 12 at 83, compound 32.
`As discussed above, as Illumina “sequenced DNA templates by repeated
`cycles of polymerase-directed single base extension” using nucleotide
`analogues, including adenine deoxyribonucleotide analogues, it follows
`that these nucleotide analogues are recognized as a substrate by a DNA
`polymerase, are incorporated at the end of a growing strand of DNA
`during a DNA polymerase reaction, and are capable of forming hydrogen
`bonds with thymine or a thymine nucleotide analogue.
`
`Illumina also discloses using tris(2-carboxyethyl)phosphine (TCEP) “to
`remove the fluorescent dye [i.e. tag] and side arm from a linker attached
`to the base and simultaneously regenerate a 3′ hydroxyl group ready for
`the next cycle of nucleotide addition (Supplementary Fig. 1b).” Ex. 4 at
`53. Thus, Illumina’s sequencing chemistry results in an adenine
`deoxyribonucleotide that produces a 3′-OH group on the deoxyribose
`upon cleavage of R and no longer includes a tag on the base upon
`cleavage of Y.
`
`Illumina’s sequencing chemistry uses adenine deoxyribonucleotide
`analogues.
`“To ensure base-by-base nucleotide incorporation in a stepwise manner,
`we used a set of four reversible terminators, 3′-O-azidomethyl 2′-
`deoxynucleoside triphosphates (A, C, G and T), each labelled with a
`
`4
`
`

`

`Case 1:19-cv-01681-CFC-SRF Document 1-8 Filed 09/10/19 Page 6 of 9 PageID #: 202
`
`0 II
`I
`0-- P-
`o-
`
`0 -
`
`o
`~-
`1-
`o·
`
`o
`II
`0 - P-
`!-
`
`0
`
`wherein R (a) represents a small, chemically cleavable,
`chemical group capping the oxygen at the 3′ position of
`the deoxyribose of the deoxyribonucleotide analogue,
`(b) does not interfere with recognition of the analogue as
`a substrate by a DNA polymerase, (c) is stable during a
`DNA polymerase reaction, and (d) does not contain a
`ketone group;
`
`different removable fluorophore (Supplementary Fig. 1a).” Ex. 4 at 53.
`
`a
`
`Ex. 5 at 14, Fig. 1a. Although only the structure for a thymine
`deoxyribonucleotide analogue is provided, Bentley indicates that the A, C,
`and G nucleotides have the same general structure. Ex. 4 at 53.
`On information and belief, Illumina uses an adenine deoxyribonucleotide
`analogue with a linker attached to the 7-deaza position of the adenine as
`shown in the claimed structure. Ex. 12 at 83, compound 32 (showing a
`linker attached to the 7-deaza position of an adenine).
`As shown in Fig. 1a of Supplementary Information to Bentley, Illumina
`uses an azidomethyl group (CH2N3) at position R (highlighted below).
`The azidomethyl group is a small chemically cleavable, chemical group,
`and does not contain a ketone group.
`
`{l
`
`5
`
`

`

`Case 1:19-cv-01681-CFC-SRF Document 1-8 Filed 09/10/19 Page 7 of 9 PageID #: 203
`
`wherein OR is not a methoxy group, an ester group, or
`an allyl ether group;
`
`wherein the covalent bond between the 3′-oxygen and R
`is stable during a DNA polymerase reaction;
`
`Ex. 5 at 14, Fig. 1a. Illumina uses these modified nucleotides for
`sequencing. Ex. 4 at 53 (“We sequenced DNA templates by repeated
`cycles of polymerase-directed single base extension.”). Since Illumina
`uses these nucleotides successfully in a polymerase reaction to
`accomplish DNA sequencing, it follows that the azidomethyl group does
`not interfere with recognition of the analogue as a substrate by a DNA
`polymerase and is stable during a DNA polymerase reaction.
`
`Illumina uses an azidomethyl group to cap the 3′-OH of its nucleotide to
`form an OR moiety. This OR moiety is not a methoxy group, an ester
`group, or an allyl either group.
`
`As Illumina uses nucleotides with an azidomethyl group “[t]o ensure
`base-by-base nucleotide incorporation in a stepwise manner,” it follows
`that the bond between the 3′-oxygen and R is stable during a DNA
`polymerase reaction. Ex. 4 at 53.
`
`wherein tag represents a detectable fluorescent moiety; As shown in Fig. 1a below, Illumina’s modified nucleotides contain a
`fluorescent moiety tag (highlighted below).
`
`a
`
`A
`0Z0--- 0
`
`0
`
`'
`
`HN
`
`Y N~O
`'t)
`
`II
`0
`
`H
`
`~
`
`N,
`1·
`o ~o
`
`0
`
`~o "~~ Q
`~ " ~
`
`0
`
`O......_,,..N,
`
`Ex. 5 at 14, Fig. 1a.
`
`wherein Y represents a chemically cleavable, chemical
`
`As shown in Fig. 1a below, Illumina’s modified nucleotides use a
`
`6
`
`

`

`Case 1:19-cv-01681-CFC-SRF Document 1-8 Filed 09/10/19 Page 8 of 9 PageID #: 204
`
`linker which (a) does not interfere with recognition of
`the analogue as a substrate by a DNA polymerase and
`(b) is stable during a DNA polymerase reaction; and
`
`chemically cleavable linker (highlighted below).
`
`Ex. 5 at 14, Fig. 1a. Illumina has indicated that this linker is chemically
`cleavable using tris(2-carboxyethyl)phosphine (TCEP). Ex. 4 at 53.
`
`As Illumina “sequenced DNA templates by repeated cycles of
`polymerase-directed single base extension” using nucleotides with this
`linker, it follows that this linker (a) does not interfere with recognition of
`the analogue as a substrate by a DNA polymerase and (b) is stable during
`a DNA polymerase reaction. Ex. 4 at 53 (emphasis added); Ex. 5 at 33,
`Figure S13 (showing “Illumina sequence reads” identifying the A base
`resulting from incorporation by a DNA polymerase of an adenine
`deoxyribonucleotide analogue having a label attached via a chemically
`cleavable, chemical linker); Ex. 12 at 83, compound 32.
`As discussed above, as Illumina “sequenced DNA templates by repeated
`cycles of polymerase-directed single base extension” using nucleotide
`analogues, including adenine deoxyribonucleotide analogues, it follows
`that these nucleotide analogues are recognized as a substrate by a DNA
`polymerase, are incorporated at the end of a growing strand of DNA
`during a DNA polymerase reaction, and are capable of forming hydrogen
`bonds with thymine or a thymine nucleotide analogue.
`
`7
`
`wherein the adenine deoxyribonucleotide analogue:
`
`i)
`
`ii)
`
`is recognized as a substrate by a DNA
`polymerase,
`
`is incorporated at the end of a growing strand of
`DNA during a DNA polymerase reaction,
`
`iii)
`
`produces a 3′-OH group on the deoxyribose upon
`
`

`

`Case 1:19-cv-01681-CFC-SRF Document 1-8 Filed 09/10/19 Page 9 of 9 PageID #: 205
`
`cleavage of R,
`
`iv)
`
`v)
`
`no longer includes a tag on the base upon
`cleavage of Y, and
`
`is capable of forming hydrogen bonds with
`thymine or a thymine nucleotide analogue.
`
`Illumina also discloses using tris(2-carboxyethyl)phosphine (TCEP) “to
`remove the fluorescent dye [i.e. tag] and side arm from a linker attached
`to the base and simultaneously regenerate a 3′ hydroxyl group ready for
`the next cycle of nucleotide addition (Supplementary Fig. 1b).” Ex. 4 at
`53. Thus, Illumina’s sequencing chemistry results in an adenine
`deoxyribonucleotide that produces a 3′-OH group on the deoxyribose
`upon cleavage of R and no longer includes a tag on the base upon
`cleavage of Y.
`
`8
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket